Philadelphia, PA – Anapol Weiss has filed a petition before the United States Judicial Panel on Multidistrict Litigation (JPML) seeking to consolidate all federal lawsuits involving Depo-Provera (Depot Medroxyprogesterone Acetate), a contraceptive injection linked to the development of cerebral meningiomas. The motion was filed on December 10, 2024.
The petition requests that the pending cases, currently scattered across multiple federal courts, be transferred for coordinated or consolidated pretrial proceedings. Anapol Weiss proposes the U.S. District Court for the Central District of California as the most suitable venue due to the concentration of cases and Judge Josephine Staton’s experience in managing complex litigation, including prior MDLs. Alternatively, the petition requests the U.S. District Court for the Northern District of California as a suitable venue under the oversight of either Judge William Orrick or Judge Jon Tigar, both very experienced jurists in MDL practice.
Depo-Provera, manufactured by Pfizer Inc. and affiliated distributors, has been linked to severe health complications, including cerebral meningiomas, a type of brain tumor. The lawsuits allege that Pfizer and its affiliates failed to adequately warn users about the risks associated with the contraceptive.
Find Out if You Qualify For the Depo-Provera Lawsuit
Speak With Our Nationally Recognized Women's Health Litigation Team
215-608-9645Currently, 28 cases are pending in eight jurisdictions across the United States, including California, Indiana, Nevada, and Massachusetts. Centralization of these cases would eliminate duplicative discovery, prevent inconsistent rulings, and promote efficient resolution for affected individuals.
“This litigation involves critical women's health issues, and centralization will allow for a streamlined process to achieve justice for those harmed,” said Tracy A. Finken, Esq., Partner at Anapol Weiss.
Anapol Weiss remains at the forefront of holding pharmaceutical companies accountable for negligence and failure to warn patients of dangerous side effects.
For more information about the Depo-Provera litigation, or if you or a loved one has been affected, please contact Tracy Finken.
